Educational only — prices and formulary rules change
This summarizes publicly described Canadian retail bands for Health Canada–authorized Mounjaro (tirzepatide) and typical Saskatchewan Drug Plan behaviour for readers in Regina, Saskatoon, Moose Jaw, and rural SK. It is not a coverage determination, not medical advice, and not a personal price quote. Confirm the live Saskatchewan Formulary, your plan booklet, and today’s pharmacy price with a licensed Canadian clinician or pharmacist. Flatland Health does not submit prior-authorization requests and does not sell or import medication.
Direct answer
In Saskatchewan, cash-pay Mounjaro KwikPens often land roughly in the C$405–$750 per ~4-week supply illustrative band depending on dose, pharmacy, and dispensing — with starter 2.5 mg / 5 mg pens toward the lower end and 12.5 mg / 15 mg toward the top. On the public side, tirzepatide is generally not a listed Saskatchewan Drug Plan or Exception Drug Status benefit as of this writing (unlike many type 2 diabetes Ozempic EDS claims). Most SK residents either pay cash or chase private prior authorization. Always re-check the live formulary and ask your pharmacist.
Illustrative retail cash prices (Regina, Saskatoon, Moose Jaw)
Mounjaro in Canada is typically dispensed as a KwikPen (multi-dose vial format has generally been discontinued). Mid-2026 illustrative Canadian list / cash bands reported after late-2025 manufacturer price adjustments (confirm before you fill):
| KwikPen strength (illustrative) | Rough cash band / ~4 weeks | What to confirm |
|---|---|---|
| 2.5 mg or 5 mg | Often ~C$405–$430 | DIN, stock, membership / loyalty rules |
| 7.5 mg or 10 mg | Often ~C$565–$590 | Whether your plan prefers a different DIN |
| 12.5 mg or 15 mg | Often ~C$725–$750 | Multi-pen fill once dose-stable |
| SK dispensing fee | Often ~C$9–$14+ per fill | Ask about multi-pen / one-fee options |
- Regina / Saskatoon big-box: often toward the lower end of a band when stocked; call Costco / Walmart-style pharmacies with the DIN.
- Full-service chains: Shoppers, Rexall, and grocery pharmacies can run higher once dispensing is included.
- Moose Jaw / smaller centres: similar bands, fewer quotes to compare — still worth calling two pharmacies.
- No generic tirzepatide: unlike Apo-Semaglutide for some Ozempic situations, there is typically no authorized generic Mounjaro shortcut in the near term. Molecule choice is a clinician decision — see semaglutide vs tirzepatide in Canada.
These are illustrative ranges, not guaranteed quotes. Never invent a co-pay from this page — your private plan’s prior authorization and deductible rules decide out-of-pocket when coverage applies.
Saskatchewan Drug Plan reality (verify live formulary)
Search the Saskatchewan Formulary online for “Mounjaro” or “tirzepatide.” As of mid–late 2026 reporting, Mounjaro is generally not listed as a Drug Plan or EDS benefit. Prairie public coverage for tirzepatide has been described as under review or not yet listed in several provinces — that can change after CADTH / pCPA and provincial decisions, so treat any “not covered” statement as time-stamped.
Contrast that with Ozempic, which may be an Exception Drug Status benefit for type 2 diabetes when published criteria are met. That pathway does not automatically transfer to Mounjaro. Deep dives:
Primary sources to re-check before you budget:
Private / employer plans in Saskatchewan
Many workplace group plans in SK treat Mounjaro as a specialty diabetes (or separately coded) benefit with prior authorization. Weight-management uses, annual maximums, and preferred-product rules vary wildly. We cannot invent your co-pay.
- Ask HR or the insurer for the actual prior-authorization form and whether tirzepatide DINs are listed, carved out, or capped.
- A clinician’s prescription does not equal plan approval — and a denied claim may need a documented appeal with complete history.
- Manufacturer savings programs (for example Lilly’s Canadian patient-support / savings pathways advertised for privately insured or cash-pay patients) may reduce out-of-pocket in some cases. Eligibility, stacking with insurance, and exclusions are program-specific — verify on the official Lilly Canada Mounjaro site, not from this page’s numbers.
Three scenarios
Scenario A — Regina resident, type 2 diabetes, no private drug benefits. Expect full cash-pay at illustrative retail (~$405–$750/month band by dose) plus dispensing. Public Drug Plan help for Mounjaro is typically unavailable until a formulary listing appears. Ask your clinician whether a Health Canada–authorized alternative with EDS (such as Ozempic when criteria fit) is clinically appropriate — that is a medical decision, not a cost hack we can recommend from here.
Scenario B — Saskatoon resident, employer plan with prior auth approved. After approval, claims may adjudicate at plan percentage / deductible rules rather than full retail. Out-of-pocket is still plan-specific. Keep renewal dates on a calendar if authorization is time-limited.
Scenario C — Moose Jaw resident, weight management, no diabetes diagnosis on file. Budget private prior auth (if the plan allows that indication) or cash-pay. Do not expect the Saskatchewan Drug Plan’s Ozempic EDS diabetes pathway to behave like a Mounjaro coupon. Compare SK-serving clinics in our provider directory for visit + partner-pharmacy pricing — prescription not guaranteed.
Legit ways to save (not imports)
- Pharmacy shop. Call Regina, Saskatoon, or Moose Jaw pharmacies with the DIN and ask for today’s cash price. Gaps of tens of dollars per pen are common.
- Multi-pen fills. Once dose-stable, ask whether a multi-pen dispense is clinically appropriate — one dispensing fee instead of several.
- Prior-authorization diligence. If a private claim denies, ask which criteria were missing; incomplete history is a frequent fixable failure.
- Official manufacturer support. Check Lilly Canada’s Mounjaro patient resources for any current savings or support program you may qualify for. Do not rely on third-party “coupon” sites that push gray-market product.
- Telehealth + partner pharmacy pricing. Some Saskatchewan-serving clinics in our provider directory may quote below local retail through a partner pharmacy — compare, don’t assume.
What you should not do: buy “Mounjaro,” “tirzepatide,” or research-use vials from gray-market or overseas sellers. Counterfeit and contaminated products have been documented in international shipments. There is no legitimate Canadian shortcut that undercuts authorized pharmacy channels by importing unknown pens. See also research-use-only peptides — the Canadian truth.
FAQ
How much does Mounjaro cost in Regina or Saskatoon?
Illustrative mid-2026 KwikPen cash bands are often roughly C$405–$430 (2.5 / 5 mg), C$565–$590 (7.5 / 10 mg), and C$725–$750 (12.5 / 15 mg) per ~4-week supply, before SK dispensing fees. Confirm at the pharmacy — this is not your personal quote.
Does the Saskatchewan Drug Plan cover Mounjaro?
Generally no listing as of this writing. Re-search the live Saskatchewan Formulary. Ozempic EDS for type 2 diabetes is a different product and pathway — see Ozempic EDS Saskatchewan.
Is there a cheaper generic Mounjaro?
Not in the near term for tirzepatide. Authorized generic semaglutide may be cheaper when clinically appropriate, but it is a different molecule — discuss options with a licensed Canadian clinician.
Can telehealth prescribe Mounjaro for Saskatchewan patients?
Licensed clinicians serving Saskatchewan — including some telehealth pathways — may assess appropriateness and help with private-plan paperwork. Coverage approval and a prescription are never guaranteed. Start with the provider directory or eligibility quiz.
Prairie twins: Ozempic cost in Saskatchewan · Ozempic cost in Alberta · Semaglutide vs tirzepatide.
Saskatchewan GLP-1 access → Compare SK-serving providers
Informational eligibility quiz Felix details May be affiliate